InVivo Therapeutics Holdings Corp. (OTCMKTS:NVIV) Struggling With The Market

InVivo Therapeutics Holdings Corp. (OTCMKTS:NVIV) had a bit of a tumble on Wednesday, but managed to recover during the last thirty minutes of the session that followed.

NVIV managed an impressive jump, in spite of the reduced dollar volume, and almost managed to break the $1 barrier, but was cut a bit short by the closing bell. Still, this sudden peak of interest gives some investors the hope that the ticker will do even better today.

As it is, the only reason for NVIV not to go any higher is the fact that the company is still in the early stages in its research. There are some hopeful rumors that the company will be fast-tracked by the FDA, but that shortcut can only be taken after NVIV has come up marketable product. First the science has to check out and perfecting a technology as complex as the Neuro-Spinal Scaffold may take quite a bit of time.

In similar circumstances, logic dictates that the ticker should remain stable as long as there are no significant developments that could influence its direction. Still, OTC Markets penny stocks being as volatile as they are, it wouldn’t be surprising to see NVIV stock prices jump for no other reason but hype or plummet unexpectedly, in spite of the lack of bad news.

As it stands, if hype or panic does not push the ticker in the mean time, it is highly likely that the next big movement NVIV will register will happen when it announces more results from its research. If the news are good, the ticker will probably soar once again. If they are not – it will most likely be headed straight down.